Cargando…
Detection of genetic mutations in patients with breast cancer from Saudi Arabia using Ion AmpliSeq™ Cancer Hotspot Panel v.2.0
Next-Generation Sequencing allows for quick and precise sequencing of multiple genes concurrently. Recently, this technology has been employed for the identification of novel gene mutations responsible for disease manifestation among breast cancer (BC) patients, the most common type of cancer amongs...
Autores principales: | Messaoudi, Safia A., Al Sharhan, Nourah A., Alharthi, Bandar, Babu, Saranya R., Alsaleh, Abrar B., Alasiri, Alanoud M., Assidi, Mourad, Buhmeida, Abdelbaset, Almawi, Wassim Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889543/ https://www.ncbi.nlm.nih.gov/pubmed/35251613 http://dx.doi.org/10.3892/br.2022.1509 |
Ejemplares similares
-
Utility of Circulating Cell-Free DNA in Assessing Microsatellite Instability and Loss of Heterozygosity in Breast Cancer Using Human Identification Approach
por: Al Sharhan, Norah A., et al.
Publicado: (2022) -
Identification of Novel Mutations in Colorectal Cancer Patients Using AmpliSeq Comprehensive Cancer Panel
por: Almuzzaini, Bader, et al.
Publicado: (2021) -
Evaluation of the Performance of AmpliSeq and SureSelect Exome Sequencing Libraries for Ion Proton
por: Gampawar, Piyush, et al.
Publicado: (2019) -
Medicine and health of 21st Century: Not just a high biotech-driven solution
por: Assidi, Mourad, et al.
Publicado: (2022) -
Current Healthcare Systems in Light of Hyperendemic NCDs and the COVID-19 Pandemic: Time to Change
por: Buhmeida, Abdelbaset, et al.
Publicado: (2023)